Published in Science on August 28, 1992
Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci U S A (1998) 2.71
Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways. Proc Natl Acad Sci U S A (2008) 1.69
The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology (2013) 1.56
Peripheral mechanisms of pain and analgesia. Brain Res Rev (2008) 1.55
Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior. Pain (2013) 1.44
COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer (2007) 1.40
Intrathecal ketorolac does not improve acute or chronic pain after hip arthroplasty: a randomized controlled trial. J Anesth (2014) 1.38
Acute pain management in children. J Pain Res (2010) 1.34
In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br J Pharmacol (1995) 1.33
Effects of intrathecal ketorolac on human experimental pain. Anesthesiology (2010) 1.31
Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest (2005) 1.30
The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci U S A (1999) 1.27
Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia. J Neurosci (2011) 1.26
COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice. J Clin Invest (2009) 1.18
Use and abuse of over-the-counter analgesic agents. J Psychiatry Neurosci (1998) 1.16
The mechanisms of action of NSAIDs in analgesia. Drugs (1996) 1.14
Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2. Br J Pharmacol (2005) 1.13
Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proc Natl Acad Sci U S A (2012) 1.13
Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br J Pharmacol (2001) 1.11
Distinct neurochemical features of acute and persistent pain. Proc Natl Acad Sci U S A (1999) 1.08
Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice. Br J Pharmacol (1994) 1.04
The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats. Br J Pharmacol (1995) 1.03
Activation of presynaptic NMDA receptors coupled to NaV1.8-resistant sodium channel C-fibers causes retrograde mechanical nociceptor sensitization. Proc Natl Acad Sci U S A (2003) 1.02
The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects. Drugs (1994) 1.01
The pharmacotherapy of chronic pain: a review. Pain Res Manag (2006) 1.01
Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons. Mol Pain (2007) 1.00
Activin acts with nerve growth factor to regulate calcitonin gene-related peptide mRNA in sensory neurons. Neuroscience (2007) 0.97
Dose-related effects of ibuprofen on pain-related potentials. Br J Clin Pharmacol (1994) 0.96
Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion. Neuroscience (2007) 0.94
Pathophysiological basis of acute inflammatory hyperaemia in the rat knee: roles of cyclo-oxygenase-1 and -2. J Physiol (2002) 0.93
Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br J Pharmacol (1999) 0.92
Drug therapy in dental practice: nonopioid and opioid analgesics. Anesth Prog (2005) 0.92
Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats. Pain (2007) 0.90
Pain management: Part 1: Managing acute and postoperative dental pain. Anesth Prog (2010) 0.89
Endoperoxide 4 receptors play a role in evoking the exercise pressor reflex in rats with simulated peripheral artery disease. J Physiol (2013) 0.87
A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitization. Drugs (1994) 0.86
Pathophysiology of joint pain. Ann Rheum Dis (1996) 0.86
Selective activation of microglia facilitates synaptic strength. J Neurosci (2015) 0.85
Pain management for dentists: the role of ibuprofen. Ann Stomatol (Roma) (2012) 0.85
Constitutive cyclooxygenase-2 is involved in central nociceptive processes in humans. Anesthesiology (2007) 0.85
Electroacupuncture mediates extracellular signal-regulated kinase 1/2 pathways in the spinal cord of rats with inflammatory pain. BMC Complement Altern Med (2014) 0.85
Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link. Arthritis Res Ther (2004) 0.84
In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin. Br J Pharmacol (1999) 0.84
Functional neurokinin and NMDA receptor activity in an animal naturally lacking substance P: the naked mole-rat. PLoS One (2010) 0.83
Intrathecal adenosine A1 receptor agonist attenuates hyperalgesia without inhibiting spinal glutamate release in the rat. Cell Mol Neurobiol (2003) 0.83
Inflammatory mediators potentiate high affinity GABA(A) currents in rat dorsal root ganglion neurons. Neurosci Lett (2012) 0.82
Spinal amino acid release and repeated withdrawal in spinal morphine tolerant rats. Br J Pharmacol (2003) 0.81
The dose-related effects of paracetamol on hyperalgesia and nociception in the rat. Br J Pharmacol (1996) 0.80
Milnacipran inhibits glutamatergic N-methyl-D-aspartate receptor activity in spinal dorsal horn neurons. Mol Pain (2012) 0.80
[Opioid-induced analgesia and hyperalgesia]. Schmerz (2005) 0.79
Co-induction of cyclooxygenase-2 [correction of cyclooxyenase-2] and early growth response gene (Egr-1) in spinal cord in a clinical model of persistent inflammation and hyperalgesia. Mol Pain (2011) 0.79
Secondary hyperalgesia in the rat first degree burn model is independent of spinal cyclooxygenase and nitric oxide synthase. Eur J Pharmacol (2008) 0.78
Acetaminophen prevents hyperalgesia in central pain cascade. Neurosci Lett (2008) 0.77
Spinal mediators of hyperalgesia. Drugs (1994) 0.76
Antinociceptive activity of the tachykinin NK1 receptor antagonist, CP-99,994, in conscious gerbils. Br J Pharmacol (1995) 0.76
Clinical Pharmacology and Cardiovascular Safety of Naproxen. Am J Cardiovasc Drugs (2016) 0.75
No preemptive analgesic effect of preoperative ketorolac administration following total abdominal hysterectomy: A randomized study. Saudi J Anaesth (2017) 0.75
NSAIDs and Acute Pancreatitis: A Systematic Review. Pharmaceuticals (Basel) (2010) 0.75
Role of neurokinin type 1 receptor in nociception at the periphery and the spinal level in the rat. Spinal Cord (2015) 0.75
Effect of Premedication with Indomethacin and Ibuprofen on Postoperative Endodontic Pain: A Clinical Trial. Iran Endod J (2015) 0.75
The Antinociceptive Effect of Light-Emitting Diode Irradiation on Incised Wounds Is Correlated with Changes in Cyclooxygenase 2 Activity, Prostaglandin E2, and Proinflammatory Cytokines. Pain Res Manag (2017) 0.75
Synergistic depression of NMDA receptor-mediated transmission by ketamine, ketoprofen and L-NAME combinations in neonatal rat spinal cords in vitro. Br J Pharmacol (2007) 0.75
Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats. Br J Pharmacol (1995) 0.75
Interaction between maropitant and carprofen on sparing of the minimum alveolar concentration for blunting adrenergic response (MAC-BAR) of sevoflurane in dogs. J Vet Med Sci (2017) 0.75
Distribution of Spinal Sensitization Evoked by Inflammatory Pain Using Local Spinal Cord Glucose Utilization Combined with (3) H-Phorbol 12,13-Dibutyrate Binding in Rats. ISRN Pain (2013) 0.75
Advanced Genetic Testing Comes to the Pain Clinic to Make a Diagnosis of Paroxysmal Extreme Pain Disorder. Case Rep Neurol Med (2016) 0.75
Evaluation of Postoperative Anti-nociceptive Efficacy of Intrathecal Dexketoprofen in Rats. Balkan Med J (2016) 0.75
Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05
Analgesia mediated by a direct spinal action of narcotics. Science (1976) 2.84
Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci (2001) 2.33
Control of body temperature in the unanaesthetized monkey by cholinergic and aminergic systems in the hypothalamus. J Physiol (1969) 2.23
Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther (1992) 2.17
Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J Pharmacol Exp Ther (1977) 2.11
Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature (1980) 2.08
Spinal opiate analgesia: characteristics and principles of action. Pain (1981) 1.97
Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg (1989) 1.96
Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology (1993) 1.86
Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav (1985) 1.85
Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology (1995) 1.83
In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J Pharmacol Exp Ther (1984) 1.83
Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J Neurosci Methods (1997) 1.82
Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology (1981) 1.80
Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray. Brain Res (1976) 1.66
Release of substance P from the cat spinal cord. J Physiol (1987) 1.52
Thermoregulation around a new set-point' established in the monkey by altering the ratio of sodium to calcium ions within the hypothalamus. J Physiol (1971) 1.51
Long-term spinal analgesic delivery: a review of the preclinical and clinical literature. Reg Anesth Pain Med (2000) 1.51
Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther (1997) 1.50
Effect of continuous spinal remifentanil infusion on behaviour and spinal glutamate release evoked by subcutaneous formalin in the rat. Br J Anaesth (1998) 1.45
Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther (1994) 1.44
Differential cross-tolerance between intrathecal morphine and sufentanil in the rat. Anesthesiology (1990) 1.42
Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J Pharmacol Exp Ther (1980) 1.39
Narcotic analgestics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain (1978) 1.37
The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain (1997) 1.36
Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J Pharmacol Exp Ther (1998) 1.36
Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc (1981) 1.35
Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J Neurosci (1994) 1.34
Intrathecal capsaicin depletes substance P in the rat spinal cord and produces prolonged thermal analgesia. Science (1979) 1.33
The physiology and pharmacology of spinal opiates. Annu Rev Pharmacol Toxicol (1985) 1.31
Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain (1996) 1.27
Cardiorespiratory and spinal cord blood flow effects of intrathecal neostigmine methylsulfate, clonidine, and their combination in sheep. Anesthesiology (1995) 1.26
Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain (1993) 1.26
Analgetic actions of intrathecal opiates in cat and primate. Brain Res (1978) 1.24
Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth (1997) 1.23
Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J Neurosci (1995) 1.20
Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems. Anesthesiology (1994) 1.19
Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol (1978) 1.19
Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats. J Pharmacol Exp Ther (1992) 1.17
Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur J Pharmacol (1985) 1.17
Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev (1993) 1.16
Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br J Pharmacol (2010) 1.16
Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Res (1984) 1.15
Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther (1979) 1.15
Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology (1992) 1.15
Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain (2000) 1.14
Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat. Brain Res (1986) 1.13
Analgesic and neurotoxic effects of intrathecal corticosteroids in rats. Anesthesiology (1994) 1.12
An extensive exploration of the rat brain for sites mediating prostaglandin-induced hyperthermia. Brain Res (1977) 1.11
Micturition in rats: a chronic model for study of bladder function and effect of anesthetics. Am J Physiol (1986) 1.10
Drug effects on urinary bladder tone during spinal morphine-induced inhibition of the micturition reflex in unanesthetized rats. Anesthesiology (1988) 1.10
Epidural injections of bupivacaine, morphine, fentanyl, lofentanil, and DADL in chronically implanted rats: a pharmacologic and pathologic study. Anesthesiology (1986) 1.10
Multiple opioid receptor systems in brain and spinal cord: Part I. Eur J Anaesthesiol (1984) 1.10
Spinal noradrenergic terminal system mediates antinociception. Brain Res (1980) 1.10
Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg (1990) 1.09
Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res (1979) 1.08
The pharmacokinetics of lignocaine in humans during a computer-controlled infusion. Eur J Pain (1997) 1.08
Sites of action of opiates in production of analgesia. Prog Brain Res (1988) 1.08
Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J Pharmacol Exp Ther (1995) 1.08
Properties of two unmyelinated fibre tracts of the central nervous system: lateral Lissauer tract, and parallel fibres of the cerebellum. J Physiol (1978) 1.07
Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Sci (1991) 1.06
Studies on the antagonism by raphe lesions of the antinociceptive action of systemic morphine. Eur J Pharmacol (1977) 1.06
Epidural ketamine: a useful, mechanistically novel adjuvant for epidural morphine? Reg Anesth (1997) 1.06
Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg (1997) 1.06
Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem. Brain Res (1991) 1.06
Development of GABA-sensitive spasticity and rigidity in rats after transient spinal cord ischemia: a qualitative and quantitative electrophysiological and histopathological study. Neuroscience (2006) 1.05
Antinociceptive properties of intrathecal dexmedetomidine in rats. Eur J Pharmacol (1991) 1.05
The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship. J Pharmacol Exp Ther (1991) 1.04
An improved method for chronic catheterization of the rat spinal subarachnoid space. Physiol Behav (1981) 1.04
The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats. Br J Pharmacol (1995) 1.03
Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia. Anesthesiology (1997) 1.03
Changes in body temperature of the unanaesthetized monkey produced by sodium and calcium ions perfused through the cerebral ventricles. J Physiol (1971) 1.02
Vincristine-induced allodynia in the rat. Pain (2001) 1.02
Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain (1992) 1.02
Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J Pharmacol Exp Ther (1996) 1.02
Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity. J Pharmacol Exp Ther (1986) 1.02
Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids. Neuroscience (1999) 1.02
Pain models display differential sensitivity to Ca2+-permeable non-NMDA glutamate receptor antagonists. Anesthesiology (2001) 1.02
Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. J Pharmacol Exp Ther (1989) 1.02
Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB). J Pharmacol Exp Ther (1992) 1.01
Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: lack of a role in allodynia development. J Neurosci (1999) 1.00
Peripheral and central substrates involved in the rostrad transmission of nociceptive information. Pain (1982) 0.99
Monoamine release from cat spinal cord by somatic stimuli: an intrinsic modulatory system. J Physiol (1981) 0.99
Characterization of the effects of gabapentin and 3-isobutyl-gamma-aminobutyric acid on substance P-induced thermal hyperalgesia. Anesthesiology (1998) 0.99
Inhibition of spinal protein kinase C reduces nerve injury-induced tactile allodynia in neuropathic rats. Neurosci Lett (1999) 0.99
Antagonism of stimulation-produced antinociception by intrathecal administration of methysergide or phentolamine. Brain Res (1984) 0.99
Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance. J Pharmacol Exp Ther (1990) 0.98
Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci Lett (1995) 0.98
Factors governing release of methionine enkephalin-like immunoreactivity from mesencephalon and spinal cord of the cat in vivo. J Neurophysiol (1981) 0.98
Efflux of 5-hydroxytryptamine and noradrenaline into spinal cord superfusates during stimulation of the rat medulla. J Physiol (1985) 0.98
High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications. Anesthesiology (1986) 0.98
Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology (1994) 0.98
An animal model of pain produced by systemic administration of an immunotherapeutic anti-ganglioside antibody. Pain (1997) 0.97
Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABA(A) receptor antagonist. Neuroscience (2000) 0.96
A novel model of primary and secondary hyperalgesia after mild thermal injury in the rat. Neurosci Lett (1998) 0.96
Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia. Brain Res (2000) 0.95
Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine. Anesthesiology (1998) 0.95